{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:42:06Z","timestamp":1788126126639,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,5,7]],"date-time":"2011-05-07T00:00:00Z","timestamp":1304726400000},"content-version":"vor","delay-in-days":310,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Pesquisas"},{"name":"Instituto Oswaldo Cruz"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ijantimicag.2010.03.006","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T04:31:39Z","timestamp":1273293099000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Bianca P.","family":"Olivieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Tibisay","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange L.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Claudia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio A.","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania C.","family":"Ara\u00fajo-Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.03.006_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006","journal-title":"Trends Parasitol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2010.03.006_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib4","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","author":"Urbina","year":"2009","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0020-7519(01)00171-0","article-title":"Parasite polyclonal activators: new targets for vaccination approaches?","volume":"31","author":"Minoprio","year":"2001","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib7","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/AAC.46.12.3790-3796.2002","article-title":"Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection","volume":"46","author":"Olivieri","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/S0074-02761991000200008","article-title":"Reversibility of cardiac fibrosis in mice chronically infected with Trypanosoma cruzi, under specific chemotherapy","volume":"86","author":"Andrade","year":"1991","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0074-02761994000200017","article-title":"Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment","volume":"89","author":"Segura","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4269\/ajtmh.1989.40.252","article-title":"Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evolution of cardiac fibrosis in mice infected with Trypanosoma cruzi","volume":"40","author":"Andrade","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s004360000262","article-title":"Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy","volume":"86","author":"Souza","year":"2000","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/AAC.01170-06","article-title":"The anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas\u2019 disease is less dependent on gamma interferon than that of benznidazole","volume":"51","author":"Ferraz","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease","volume":"14","author":"Bustamante","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/AAC.00779-08","article-title":"Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection","volume":"53","author":"Ferraz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.03.006_bib15","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1371\/journal.pmed.0040332","article-title":"The challenges of Chagas disease\u2014grim outlook or glimmer of hope","volume":"4","author":"Tarleton","year":"2007","journal-title":"PLoS Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:30:39Z","timestamp":1760376639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910001214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0924857910001214"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.03.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}